The aftermath of the Merck's HIV vaccine trial
<p>Abstract</p> <p>The recently released results of the Merck's Phase IIb "test-of concept" vaccine trials have shown no protection from HIV-1 infection in the vaccinated group compared with a control group vaccinated with placebo. The study was designed to test the...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-07-01
|
Series: | Retrovirology |
Online Access: | http://www.retrovirology.com/content/5/1/56 |